Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-12

Clinical Trial Update: Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating high-volume nasal mometasone irrigations for chronic rhinosinusitis, with assessment of cortisol suppression risk as dose varies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasonex (mometasone furoate)

Snippet

Sponsor: Rush University Medical Center | Conditions: Chronic Rhinosinusitis (Diagnosis) | Phase 1 | Status: COMPLETED | Results posted: 2024-08-12